The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Treatment of Acinetobacter Infections
Abstract
Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited well-controlled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Self-citationPractice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Maragakis, L. L., & Perl, T. M. (2008) · Clinical Infectious Diseases · doi:10.1086/529198 · Cited by 969
Lodise, T. P., Lomaestro, B., & Drusano, G. L. (2007) · Clinical Infectious Diseases · doi:10.1086/510590 · Cited by 527
Scott, P., Deye, G., Srinivasan, A., Murray, C., Moran, K., Hulten, E., Fishbain, J., Craft, D., Riddell, S., Lindler, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518170 · Cited by 393
Self-citationFalagas, M. E., Bliziotis, I. A., & Siempos, I. I. (2006) · Critical Care · doi:10.1186/cc4869 · Cited by 272
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Peleg, A. Y., Potoski, B. A., Rea, R., Adams, J., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248
Self-citationManagement of meningitis due to antibiotic-resistant Acinetobacter species
Kim, B.-N., Peleg, A. Y., Lodise, T. P., Lipman, J., Li, J., Nation, R., & Paterson, D. L. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70055-6 · Cited by 244
Self-citationPetrosillo, N., Ioannidou, E., & Falagas, M. E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02061.x · Cited by 213
Tam, V. H., Schilling, A. N., Neshat, S., Poole, K., Melnick, D. A., & Coyle, E. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4920-4927.2005 · Cited by 196
Karageorgopoulos, D. E., Kelesidis, T., Kelesidis, I., & Falagas, M. E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn165 · Cited by 193
Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients
Li, C., Kuti, J. L., Nightingale, C. H., & Nicolau, D. P. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006291035 · Cited by 171
Urban, C., Go, E., Mariano, N., Berger, B. J., Avraham, I., Rubin, D., & Rahal, J. J. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.2.448 · Cited by 164
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
Bassetti, M., Repetto, E., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F., Durando, P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm509 · Cited by 163
Wood, G. C., Hanes, S. D., Croce, M. A., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/340055 · Cited by 157
de Oliveira, M. S., do Prado, G. V. B., Costa, S. F., Grinbaum, R. S., & Levin, A. S. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn128 · Cited by 149
Jaruratanasirikul, S., Sriwiriyajan, S., & Punyo, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1337-1339.2005 · Cited by 149
Jang, T. N., Lee, S.-P., Huang, C., Lee, C.-L., & Chen, W.-Y. (2009) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.06.007 · Cited by 118
Susceptibility of Acinetobacter Strains Isolated from Deployed U.S. Military Personnel
Hawley, J. S., Murray, C. K., Griffith, M. E., McElmeel, M. L., Fulcher, L. C., Hospenthal, D. R., & Jorgensen, J. H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00858-06 · Cited by 116
Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
Poulakou, G., Kontopidou, F. V., Paramythiotou, E., Kompoti, M., Katsiari, M., Mainas, E., Nicolaou, C., Yphantis, D., Antoniadou, A., Trikka‐Graphakos, E., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.02.009 · Cited by 106
Bishburg, E., & Bishburg, K. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.06.021 · Cited by 103
Cascio, A., Conti, A., Sinardi, L., Iaria, C., Angileri, F. F., Stassi, G., David, T., Versaci, A., Iaria, M., & David, A. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.06.032 · Cited by 91
Aerosolized Tobramycin in The Treatment of Ventilator-Associated Pneumonia: A Pilot Study
HALLAL, A. H., Cohn, S. M., Namias, N., et al. (2007) · Surgical Infections · doi:10.1089/sur.2006.051 · Cited by 90
Akers, K. S., Chaney, C., Barsoumian, A. E., Beckius, M. L., Zera, W. C., Yu, X., Guymon, C. H., Keen, E. F., ROBINSON, B. J., Mende, K., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02006-09 · Cited by 84
Gounden, R., Bamford, C., van Zyl-Smit, R. N., Cohen, K., & Maartens, G. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-26 · Cited by 80
Nørskov‐Lauritsen, N., Marchandin, H., & Dowzicky, M. J. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.02.003 · Cited by 57
Fatal Acinetobacter baumannii Infection with Discordant Carbapenem Susceptibility
Lesho, E. P., Wortmann, G. W., Moran, K., & Craft, D. W. (2005) · Clinical Infectious Diseases · doi:10.1086/432623 · Cited by 28
Discordance of meropenem versus imipenem activity against Acinetobacter baumannii
Ikonomidis, A., Pournaras, S., Maniatis, A. N., et al. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.07.007 · Cited by 23
Fraenkel, C., Ullberg, M., Bernander, S., Ericson, E., Larsson, P., Rydberg, J., Törnqvist, E., & Melhus, Å. (2006) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600684371 · Cited by 12
Cited by
Acinetobacter baumannii: An emerging opportunistic pathogen
Howard, A., O’Donoghue, M., Feeney, A., & Sleator, R. D. (2012) · Virulence · doi:10.4161/viru.19700 · Cited by 837
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Multidrug Resistance: An Emerging Crisis
Tanwar, J., Das, S., Fatima, Z., & Hameed, S. (2014) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2014/541340 · Cited by 657
Ayoub Moubareck, C., & Hammoudi Halat, D. (2020) · Antibiotics · doi:10.3390/antibiotics9030119 · Cited by 627
Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models
McConnell, M. J., Actis, L., & Pachón, J. (2013) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00344.x · Cited by 540
Metadata
- Authors
- Fishbain, J., & Peleg, A. Y.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07
- Volume
- 51
- Issue
- 1
- Pages
- 79-84
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2132620230
- Cited by
- 358
- References
- 31
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.